Market revenue in 2022 | USD 304.5 million |
Market revenue in 2030 | USD 560.9 million |
Growth rate | 7.9% (CAGR from 2022 to 2030) |
Largest segment | Osteoarthritis |
Fastest growing segment | Dermal Fillers |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux |
Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid market will help companies and investors design strategic landscapes.
Osteoarthritis was the largest segment with a revenue share of 53.4% in 2022. Horizon Databook has segmented the China hyaluronic acid market based on dermal fillers, osteoarthritis, ophthalmic, vesicoureteral reflux covering the revenue growth of each sub-segment from 2017 to 2030.
China is the most populated country around the world with a large geriatric population. According to United Nations, the population in China in 2019 was about 1.4 billion, and the population aged 65 and above accounts for about 11.5% (i.e., 164.5 million).
As per “Patient-centered-New Insights on Bone and Joint Health Management" report, the total number of osteoarthritis patients in China reached 61.2 million in 2017. Furthermore, the statistics of the country’s Health Organization suggests that the incidence of cataract in China among the elderly population aged 60 to 89 is as high as 80% and that in people over 90 years is 90%.
China has the third highest number of cosmetic surgeons after the U.S. and Brazil. Over 3,000 cosmetic surgeons were present in China in 2020, as per ISAPS estimates. The country is among the top three most-cited countries by foreign patients for cosmetic procedures.
Horizon Databook provides a detailed overview of country-level data and insights on the China hyaluronic acid market , including forecasts for subscribers. This country databook contains high-level insights into China hyaluronic acid market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account